Serveur d'exploration Tocilizumab - Curation (PubMed)

Index « Auteurs » - entrée « Hiroshi Kawabata »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hiroshi Kato < Hiroshi Kawabata < Hiroshi Kida  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000D14 (2016) Yasufumi Masaki ; Hiroshi Kawabata ; Kazue Takai ; Norifumi Tsukamoto ; Shino Fujimoto ; Yasuhito Ishigaki ; Nozomu Kurose ; Masaru Kojima ; Shigeo Nakamura ; Tomohiro Kinoshita ; Sadao AokiProposed diagnostic criteria, disease severity classification, and treatment strategy for a novel disorder; TAFRO syndrome.
000E58 (2016) Sumie Hiramatsu ; Koichiro Ohmura ; Hideaki Tsuji ; Hiroshi Kawabata ; Toshiyuki Kitano ; Ayuko Sogabe ; Motomu Hashimoto ; Kosaku Murakami ; Yoshitaka Imura ; Naoichiro Yukawa ; Hajime Yoshifuji ; Takao Fujii ; Akifumi Takaori-Kondo ; Tsuneyo MimoriSuccessful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
000E86 (2016) Yasufumi Masaki [Japon] ; Hiroshi Kawabata [Japon] ; Kazue Takai [Japon] ; Masaru Kojima [Japon] ; Norifumi Tsukamoto [Japon] ; Yasuhito Ishigaki [Japon] ; Nozomu Kurose [Japon] ; Makoto Ide [Japon] ; Jun Murakami [Japon] ; Kenji Nara [Japon] ; Hiroshi Yamamoto [Japon] ; Yoko Ozawa [Japon] ; Hidekazu Takahashi [Japon] ; Katsuhiro Miura [Japon] ; Tsutomu Miyauchi [Japon] ; Shinichirou Yoshida [Japon] ; Akihito Momoi [Japon] ; Nobuyasu Awano [Japon] ; Soichiro Ikushima [Japon] ; Yasunori Ohta [Japon] ; Natsue Furuta [Japon] ; Shino Fujimoto [Japon] ; Haruka Kawanami [Japon] ; Tomoyuki Sakai [Japon] ; Takafumi Kawanami [Japon] ; Yoshimasa Fujita [Japon] ; Toshihiro Fukushima [Japon] ; Shigeo Nakamura [Japon] ; Tomohiro Kinoshita [Japon] ; Sadao Aoki [Japon]Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.
001394 (2014) Motomu Hashimoto [Japon] ; Takao Fujii [Japon] ; Masahide Hamaguchi [Japon] ; Moritoshi Furu [Japon] ; Hiromu Ito [Japon] ; Chikashi Terao [Japon] ; Keiichi Yamamoto [Japon] ; Wataru Yamamoto [Japon] ; Takashi Matsuo [Japon] ; Masato Mori [Japon] ; Koichiro Ohmura [Japon] ; Hiroshi Kawabata [Japon] ; Tsuneyo Mimori [Japon]Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.
001534 (2013) Soken-Nakazawa J. Song ; Mitsuhiro Iwahashi ; Naohisa Tomosugi ; Kazuko Uno ; Jiro Yamana ; Seizou Yamana ; Tomoyasu Isobe ; Hiroki Ito ; Hiroshi Kawabata ; Kazuyuki YoshizakiComparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients.
001645 (2013) Hiroshi Kawabata [Japon] ; Shin-Ichi Kotani ; Yumi Matsumura ; Tadakazu Kondo ; Tatsuya Katsurada ; Hironori Haga ; Norimitsu Kadowaki ; Akifumi Takaori-KondoSuccessful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
001646 (2013) Hiroshi Kawabata [Japon] ; Norimitsu Kadowaki ; Momoko Nishikori ; Toshio Kitawaki ; Tadakazu Kondo ; Takayuki Ishikawa ; Hajime Yoshifuji ; Noriyuki Yamakawa ; Yoshitaka Imura ; Tsuneyo Mimori ; Yumi Matsumura ; Yoshiki Miyachi ; Takeshi Matsubara ; Motoko Yanagita ; Hironori Haga ; Akifumi Takaori-KondoClinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute.
001647 (2013) Hiroshi Kawabata [Japon] ; Kazue Takai ; Masaru Kojima ; Naoya Nakamura ; Sadao Aoki ; Shigeo Nakamura ; Tomohiro Kinoshita ; Yasufumi MasakiCastleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
001B62 (2010) Soken-Nakazawa J. Song [Japon] ; Naohisa Tomosugi ; Hiroshi Kawabata ; Takayuki Ishikawa ; Teppei Nishikawa ; Kazuyuki YoshizakiDown-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.
001D73 (2007) Hiroshi Kawabata ; Naohisa Tomosugi ; Junya Kanda ; Yasuhiro Tanaka ; Kazuyuki Yoshizaki ; Takashi UchiyamaAnti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease.
001D77 (2007) Junya Kanda [Japon] ; Hiroshi Kawabata ; Yuhei Yamaji ; Tatsuo Ichinohe ; Takayuki Ishikawa ; Toshihiro Tamura ; Yutaka Furukawa ; Takeshi Kimura ; Toru Kita ; Takashi UchiyamaReversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Hiroshi Kawabata" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Hiroshi Kawabata" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Hiroshi Kawabata
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021